Your browser doesn't support javascript.
loading
ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations.
Moral-Sanz, Javier; Fernandez-Rojo, Manuel A; Potriquet, Jeremy; Mukhopadhyay, Pamela; Brust, Andreas; Wilhelm, Patrick; Smallwood, Taylor B; Clark, Richard J; Fry, Bryan G; Alewood, Paul F; Waddell, Nicola; Miles, John J; Mulvenna, Jason P; Ikonomopoulou, Maria P.
Afiliação
  • Moral-Sanz J; Translational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.
  • Fernandez-Rojo MA; Hepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.
  • Potriquet J; Diamantina Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Mukhopadhyay P; Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
  • Brust A; Infectious Diseases Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
  • Wilhelm P; AB SCIEX, 2 Gilda Court, Mulgrave, Melbourne, VIC 3170, Australia.
  • Smallwood TB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
  • Clark RJ; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Fry BG; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Alewood PF; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Waddell N; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Miles JJ; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Mulvenna JP; School of Biological Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Ikonomopoulou MP; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Toxins (Basel) ; 13(2)2021 02 14.
Article em En | MEDLINE | ID: mdl-33672955
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Sirolimo / Proteínas Proto-Oncogênicas B-raf / MAP Quinases Reguladas por Sinal Extracelular / Inibidores de Proteínas Quinases / Alvo Mecanístico do Complexo 1 de Rapamicina / Melanoma / Mutação Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Sirolimo / Proteínas Proto-Oncogênicas B-raf / MAP Quinases Reguladas por Sinal Extracelular / Inibidores de Proteínas Quinases / Alvo Mecanístico do Complexo 1 de Rapamicina / Melanoma / Mutação Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha